Skip to content

OUT OF POCKET EXPENDITURE IN TREATMENT OF CANCER IN REGIONAL CANCER INSTITUTE

THE OUT-OF-POCKET EXPENDITURE FOR MULTIMODALITY TREATMENT OF CANCER IN A REGIONAL CANCER CENTRE

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/01/039329
Enrollment
100
Registered
2022-01-11
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx

Interventions

None listed

Sponsors

PGIMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histologically proven case of any malignancy of any age. 2. Candidate for radical cancer-directed, multimodality treatment, with or without health insurance. 3. Willing to share details of expenses incurred for treatment. 4. Written informed consent

Exclusion criteria

Exclusion criteria: 1. Details of expenses already incurred but not available. 2. Candidates for palliative treatment 3. Unlikely to come for follow up after treatment

Design outcomes

Primary

MeasureTime frame
To assess the out-of-pocket expenditure and financial risk protection in selected cancer patients undergoing multimodality treatment.Timepoint: 1. Calculate direct and indirect cost of cancer treatment. 2. Estimate the out-of-pocket expenses as percentage of family income to calculate â??Catastrophic Health Expenditureâ??. 3. Identify Distress Financing by analysing how the treatment costs were borne by the family at the time of registration , at the time of end of treatment and follow-up for 3 months

Secondary

MeasureTime frame
1. Calculate direct and indirect cost of cancer treatment. 2. Estimate the out-of-pocket expenses as percentage of family income to calculate â??Catastrophic Health Expenditureâ??. 3. Identify Distress Financing by analysing how the treatment costs were borne by the family at the end of treatment.Timepoint: 1. Calculate direct and indirect cost of cancer treatment. 2. Estimate the out-of-pocket expenses as percentage of family income to calculate â??Catastrophic Health Expenditureâ??. 3. Identify Distress Financing by analysing how the treatment costs were borne by the family at the time of follow up for first three months

Countries

India

Contacts

Public ContactDr Sushmita Ghoshal

PGIMER

hardik.sharma472@gmail.com08130413211

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026